Understanding the Cellular Drivers of MS Progression and Treatment Response

At the American Academy of Neurology Annual Meeting, Amit Bar-Or, MD, director of the Center for Neuroinflammation and Neurotherapeutics, discussed recent advances in understanding the cellular immunology of Multiple Sclerosis (MS), emphasizing the role of immune cells. He highlighted the heterogeneity among patients and the need for biomarkers that can detect underlying processes driving both relapsing and progressive MS.